|
US2016000866A1
|
|
Cthrc1 receptor and methods of use thereof
|
|
CA2789485A1
|
|
Compositions and methods for the treatment of cardiac and vascular disease
|
|
WO2011049810A2
|
|
Compositions and methods for treating inflammation and fibrosis
|
|
US2011125467A1
|
|
System for optimizing treatment strategies using a patient-specific rating system
|
|
US2010124753A1
|
|
System and method for identifying erythropoietin-responsive genes
|
|
US2008176337A1
|
|
Monoclonal antibodies against osteopontin
|
|
US2007059829A1
|
|
Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
|
|
US2007255110A1
|
|
Operative vaginal speculum
|
|
US2006084599A1
|
|
Compositions, methods and kits relating to notch signaling
|
|
EP0873418A1
|
|
Factor v ratio blood test for susceptibility to thromboembolism
|
